MiRNA‐516a promotes bladder cancer metastasis by inhibiting MMP9 protein degradation via the AKT/FOXO3A/SMURF1 axis
Clinical and Translational Medicine2020Vol. 10(8), pp. e263–e263
Citations Over TimeTop 10% of 2020 papers
Yuanyuan Chang, Honglei Jin, Hongyan Li, Jiugao Ma, Zhijian Zheng, Binuo Sun, Yiting Lyu, Mengqi Lin, He Zhao, Liping Shen, Ruirui Zhang, Shuilian Wu, Weiwei Lin, Yongyong Lu, Qipeng Xie, Gang Zhang, Xing Huang, Haishan Huang
Abstract
Our findings reveal the crucial function of miR-516a in promoting BC metastasis, and elucidate the molecular mechanism involved, suggesting that miR-516a may be a promising novel diagnostic and therapeutic target for BC.
Related Papers
- The expression of MMP_2 and MMP_9 in endometrial carcinoma(2004)
- Determination of Matrix Metalloproteinase2 9 in Cultured Endometriotic Stromal Cells(2011)
- Comparative study of the expression of MMP2 and MMP9 in HepG2 cells and HCC tissues(2010)
- Recombinant Polypeptide CH50 of Fibronectin Inhibits the Expression and Activation of Matrix Metalloproteinase 2 and 9 in Melanoma(2007)
- The Expression of MMP2, MMP9, Type IV Collagen and E - CD in Bladder Transitional Cell Carcinoma and Its Clinical Significance(2003)